As an example, it is reported that SK-OV-3 ovarian cancer targeting by single-chain fragment variable (SCFv) was dictated by the binding avidity of the SCFv antibody against the human epidermal growth factor 2 (HER2) receptors [69]. This evidence concerns the gene ERBB2 and ovarian carcinoma.